Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,764 across all filing types
Latest filing 2023-08-07 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Pursuant to reg 30 of SEBI(LODR), 2015 we would like to inform that Company has commenced commercial operations of its new Oral Oncology facility at Bileshwarpura close to Indrad, Gujarat. ....
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchanges (BSE and NSE) informing about the commencement of commercial operations of a new facility by the company. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which typically covers material events or information that a listed company must disclose. The document does not contain financial data, audit information, voting results, or any detailed report. It is a regulatory announcement about a business update. Given the short length (1381 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-07 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchange (BSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the commencement of commercial operations of a new facility. The document is brief (1381 characters) and serves as an intimation or announcement rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed disclosures typical of other filing types. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-07 English
Proceeding of 50th Annual General meeting of the Company held on 07.08.2023
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchanges reporting the proceedings of the 50th Annual General Meeting (AGM) held on 7th August 2023. It lists the business transacted at the AGM, including approval of financial statements, dividend declarations, director appointments, auditor remuneration, issuance of shares, and alteration of articles. It also mentions that voting results and scrutinizer's report will be disclosed separately. The document is a summary or announcement of the AGM proceedings rather than the full AGM materials or detailed report. The document length is 3282 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of AGM proceedings.
2023-08-07 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchange listing department reporting on the proceedings of the 50th Annual General Meeting (AGM) held on 7th August 2023. It lists the business transacted at the AGM, including approval of financial statements, dividend declarations, director appointments, auditor remuneration, issuance of shares, and alteration of articles of association. It also mentions that voting results and scrutinizer's report will be disclosed separately. The document is a summary or announcement of the AGM proceedings rather than the full AGM materials or presentations. It is not the full Annual Report or financial statements themselves, nor is it a voting results declaration (which will be disclosed separately). Given the content and context, this document fits best as AGM Information (AGM-R) which covers presentations and materials shared during the AGM or summaries of the meeting proceedings. The document length is 3282 characters, which is consistent with a meeting summary rather than a full report. Confidence is high due to clear references to AGM proceedings and regulatory citations related to AGM disclosures.
2023-08-07 English
Presentation to analyst on unaudited consolidated financial result for quarter ended 30.06.2023
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a presentation to analysts on unaudited consolidated financial results for the quarter ended June 30, 2023. It includes summary revenue data for Q1 FY 2023-24. The document is a presentation of quarterly financial results to analysts, not a full quarterly report with detailed financial statements. The document length is 1975 characters, which is relatively short and consistent with a presentation rather than a full report. Therefore, the document fits the category of an Investor Presentation (IP).
2023-08-07 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a presentation to analysts on unaudited consolidated financial results for the quarter ended June 30, 2023. It includes summary revenue data for Q1 FY 2023-24. The document is a presentation of quarterly financial results to analysts, not a full quarterly report with detailed financial statements. The document length is 1975 characters, which is relatively short and consistent with a presentation rather than a full report. Therefore, the document fits the category of an Investor Presentation (IP).
2023-08-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.